This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
AEEC: Becoming an Innovation Catalyst, Teaching Plan
Applegate, Lynda M.; Weber, James; Mehta, SarahTeaching Note HBS-318107-EThis teaching plan pairs with the case, "AEEC: Becoming an Innovation Catalyst" (case no. 317011).Starting at €0.00
-
Tesla in 2015, Teaching Plan
Applegate, Lynda M.; Hull, Olivia; Mehta, SarahTeaching Note HBS-818009-EEntrepreneurshipTeaching plan for case "Tesla in 2015" (HBS case no. 817081)Starting at €0.00
-
AEEC: Becoming an Innovation Catalyst
Applegate, Lynda M.; Weber, James; Mehta, SarahCase HBS-317011-EStarting at €8.20
-
Applying Data Science and Analytics at P&G
Datar, Srikant M.; Mehta, Sarah; Hamilton, PaulCase HBS-121006-EInformation TechnologiesSet in December 2019, this case explores how P&G has applied data science and analytics to cut costs and improve outcomes across its business units. The case provides an overview of P&G's approach to data management and governance, and reviews the challenStarting at €8.20
-
MIA: Profit at the Base of the Pyramid
Applegate, Lynda M.; Davila Castilla, Jose Antonio; Mehta, Sarah; Sesia, AldoCase HBS-817073-EIn January 2016, Guillermo Jaime had just returned home to Mexico City after attending a Harvard Business School executive education program. Jaime was the founder and CEO of Mejoramiento Integral Asistido (MIA), a company providing affordable housing to low-income Mexicans living at the base of the pyramid (BOP), defined as those living on less than $10 per day. Since its launch in 2009, MIA had built nearly 25,000 homes-which provided safe shel...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future
Stern, Ariel D.; Mehta, SarahCase HBS-618025-EService and Operations ManagementIn July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial-an adaptive platform trial-to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer drugs were tested-the traditional randomized controlled trial (RCT)-was limited in many ways. While statistically rigorous and s...Starting at €8.20